FoxI1 Polyclonal Antibody

FOXI1 belongs to the forkhead family of transcription factors which is characterized by a distinct forkhead domain. The specific function of this gene has not yet been determined; however, it is possible that this gene plays an important role in the development of the cochlea and vestibulum, as well as embryogenesis. Mutations in this gene may be associated with the common cavity phenotype. Two transcript variants encoding different isoforms have been found for this gene.

The FoxI1 Polyclonal Antibody is a highly specific and reliable tool for the detection and analysis of FoxI1 protein expression in various biological samples. This antibody has been meticulously developed and validated to ensure optimal performance and accuracy in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The FoxI1 Polyclonal Antibody exhibits exceptional sensitivity and specificity, enabling the precise identification and quantification of FoxI1 protein levels in both normal and diseased tissues. Its high affinity for the target antigen ensures minimal background noise and reliable results, even in complex biological matrices.

This antibody has been rigorously tested and validated using a variety of experimental approaches, guaranteeing its reliability and reproducibility. It has been shown to exhibit excellent performance in various species, including human, mouse, and rat, making it a versatile tool for researchers working with different model systems.

The FoxI1 Polyclonal Antibody is supplied as a ready-to-use solution, eliminating the need for time-consuming and error-prone antibody preparation. Its convenient formulation allows for easy and efficient handling, saving valuable time in the laboratory.

With its exceptional performance, reliability, and ease of use, the FoxI1 Polyclonal Antibody is an indispensable tool for researchers studying the role of FoxI1 protein in various biological processes and diseases. Its high specificity and sensitivity make it an ideal choice for both basic research and clinical applications, facilitating a deeper understanding of FoxI1 function and its potential as a therapeutic target.